Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Resmed Inc shares valued at $891,286 were sold by Sandercock Brett on May 22 ’25. At $244.59 per share, Sandercock Brett sold 3,644 shares. The insider’s holdings dropped to 86,283 shares worth approximately $21.12 million following the completion of this transaction.
Also, Sandercock Brett purchased 3,644 shares, netting a total of over 891,286 in proceeds.
Before that, De Witte Jan had sold 2,000 shares from its account. In a trade valued at $486,940, the Director traded Resmed Inc shares for $243.47 each. Upon closing the transaction, the insider’s holdings decreased to 2,000 shares, worth approximately $1.42 million.
As published in their initiating research note from Morgan Stanley on March 19, 2025, Resmed Inc [RMD] has been an Overweight and the price target has been revised to $280. Analysts at Morgan Stanley started covering the stock with ‘”an Overweight”‘ outlook in a report released in mid March. As of January 16, 2025, Goldman has initiated its “Buy” rating for RMD. Earlier on January 10, 2025, Piper Sandler initiated its rating. Their recommendation was “a Neutral” for RMD stock.
Analyzing RMD Stock Performance
During the last five days, there has been a drop of approximately -1.36%. Over the course of the year, Resmed Inc shares have jumped approximately 7.03%. Shares of the company reached a 52-week high of $263.05 on 01/30/25 and a 52-week low of $199.92 on 04/07/25.
Support And Resistance Levels for Resmed Inc (RMD)
According to the 24-hour chart, there is a support level at 243.91, which, if violated, would cause prices to drop to 243.07. In the upper region, resistance lies at 246.30. The next price resistance is at 247.85. RSI (Relative Strength Index) is 56.74 on the 14-day chart, showing neutral technical sentiment.
